<DOC>
	<DOC>NCT01796691</DOC>
	<brief_summary>Comparing standard treatment versus optimized antiplatelet therapy and outcomes measures.</brief_summary>
	<brief_title>The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)</brief_title>
	<detailed_description>The study is aimed to evaluate if optimized antiplatelet treatment using a test and treat algorithm (with whole blood aggregometry) is able to improve clinical outcome of patients compared to standard treatment without platelet function testing.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>coronary stent implantation no consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>aspirin</keyword>
	<keyword>low response</keyword>
	<keyword>platelet aggregation</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Coronary Stent Implantation</keyword>
</DOC>